OpenAI GPT-Rosalind: The AI Model Accelerating Drug Discovery in 2026

OpenAI launched GPT-Rosalind on April 16, 2026 — a specialized reasoning model built from the ground up for biology, drug discovery, and translational medicine research. Named after British chemist Rosalind Franklin, whose X-ray crystallography work ...